[go: up one dir, main page]

NO954320L - Lyosfærer omfattende gonadotropin - Google Patents

Lyosfærer omfattende gonadotropin

Info

Publication number
NO954320L
NO954320L NO954320A NO954320A NO954320L NO 954320 L NO954320 L NO 954320L NO 954320 A NO954320 A NO 954320A NO 954320 A NO954320 A NO 954320A NO 954320 L NO954320 L NO 954320L
Authority
NO
Norway
Prior art keywords
pct
lyospheres
gonadotropin
sec
date
Prior art date
Application number
NO954320A
Other languages
English (en)
Other versions
NO954320D0 (no
NO311168B1 (no
Inventor
Arnold Titus Philip Skrabanja
Herman Vromans
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO954320D0 publication Critical patent/NO954320D0/no
Publication of NO954320L publication Critical patent/NO954320L/no
Publication of NO311168B1 publication Critical patent/NO311168B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19954320A 1993-04-28 1995-10-27 Lyosf¶rer omfattende gonadotropin, fremgangsmåte ved fremstilling derav og farmasöytisk preparat omfattende sådanne NO311168B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93201215 1993-04-28
PCT/EP1994/001303 WO1994025005A1 (en) 1993-04-28 1994-04-25 Lyospheres comprising gonadotropin

Publications (3)

Publication Number Publication Date
NO954320D0 NO954320D0 (no) 1995-10-27
NO954320L true NO954320L (no) 1995-10-27
NO311168B1 NO311168B1 (no) 2001-10-22

Family

ID=8213798

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19954320A NO311168B1 (no) 1993-04-28 1995-10-27 Lyosf¶rer omfattende gonadotropin, fremgangsmåte ved fremstilling derav og farmasöytisk preparat omfattende sådanne

Country Status (15)

Country Link
US (1) US5656597A (no)
EP (1) EP0695171B1 (no)
JP (1) JPH08509483A (no)
KR (1) KR100334856B1 (no)
AT (1) ATE146360T1 (no)
AU (1) AU679986B2 (no)
CA (1) CA2150251C (no)
DE (1) DE69401204T2 (no)
DK (1) DK0695171T3 (no)
ES (1) ES2098140T3 (no)
FI (1) FI112324B (no)
GR (1) GR3022510T3 (no)
NO (1) NO311168B1 (no)
NZ (1) NZ265956A (no)
WO (1) WO1994025005A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
GB2329124B (en) * 1997-09-12 2002-05-08 Hiran Asoka Malinga Ratwatte Method of forming dose units of active agents
EP1658840A1 (en) * 1999-04-05 2006-05-24 Mannkind Corporation Methods for fine powder formation
ES2261195T3 (es) 1999-04-05 2006-11-16 Mannkind Corporation Metodo de formacion de particulas finas.
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
WO2005002546A1 (en) * 2003-06-27 2005-01-13 Smithkline Beecham Corporation Stabilized topotecan liposomal composition and methods
ES2385934T3 (es) 2004-08-20 2012-08-03 Mannkind Corporation Catálisis de la síntesis de dicetopiperazina.
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
US7799344B2 (en) 2005-09-14 2010-09-21 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US8039431B2 (en) 2006-02-22 2011-10-18 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
TWI436789B (zh) 2008-01-21 2014-05-11 Intervet Int Bv 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包
WO2009109550A1 (en) 2008-03-05 2009-09-11 Sanofi Pasteur Process for stabilizing an adjuvant containing vaccine composition
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2293833T3 (en) 2008-06-13 2016-05-23 Mannkind Corp DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
JP5479465B2 (ja) 2008-06-20 2014-04-23 マンカインド コーポレイション 吸入努力をリアルタイムにプロファイルする対話式機器および方法
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US8551528B2 (en) 2009-06-12 2013-10-08 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9016147B2 (en) 2009-11-03 2015-04-28 Mannkind Corporation Apparatus and method for simulating inhalation efforts
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
MY180552A (en) 2011-04-01 2020-12-02 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2776053A1 (en) 2011-10-24 2014-09-17 MannKind Corporation Methods and compositions for treating pain
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2017066134A1 (en) * 2015-10-16 2017-04-20 Merck Sharp & Dohme Corp. Processes for preparing formulations for gastrointestinal-targeted therapies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
ATE14047T1 (de) * 1981-12-11 1985-07-15 Wyeth John & Brother Ltd Verfahren und vorrichtung zum gefrieren einer fluessigkeit.
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
CA2030551C (en) * 1989-05-01 1998-08-25 Wayne Gombotz Process for producing small particles of biologically active molecules
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations

Also Published As

Publication number Publication date
DE69401204T2 (de) 1997-06-05
NO954320D0 (no) 1995-10-27
EP0695171B1 (en) 1996-12-18
CA2150251A1 (en) 1994-11-10
ES2098140T3 (es) 1997-04-16
FI112324B (fi) 2003-11-28
DK0695171T3 (da) 1997-06-02
DE69401204D1 (de) 1997-01-30
KR950703934A (ko) 1995-11-17
KR100334856B1 (ko) 2002-11-07
WO1994025005A1 (en) 1994-11-10
ATE146360T1 (de) 1997-01-15
FI953442A0 (fi) 1995-07-14
NZ265956A (en) 1996-09-25
EP0695171A1 (en) 1996-02-07
CA2150251C (en) 2005-02-22
NO311168B1 (no) 2001-10-22
AU6648894A (en) 1994-11-21
HK1002017A1 (en) 1998-07-24
FI953442L (fi) 1995-07-14
US5656597A (en) 1997-08-12
AU679986B2 (en) 1997-07-17
JPH08509483A (ja) 1996-10-08
GR3022510T3 (en) 1997-05-31

Similar Documents

Publication Publication Date Title
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
TR27835A (tr) Sübstitüe edilmis azadiokzasikloalkenler.
HN2000000109A (es) Trifluorbutenos nematicidas
DE69326250D1 (de) Neuropeptide y antagoniste
ES2104133T3 (es) Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico.
ATE170194T1 (de) Neue inklusionskomplexe von salzen von nimesulide mit cyclodextrinen
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
DE69323191D1 (de) Wasserlösliche retinoide
AU6722498A (en) Disubstituted biphenyloxazolines
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
SE9401596D0 (sv) New compounds
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them
UA30250A (uk) Антиоксидантний засіб
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.
RU2076528C1 (ru) Штамм вируса омской геморрагической лихорадки для приготовления диагностических препаратов

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees